Frontiers in Oncology

Original Research

Published on 30 Nov 2023

Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanoma

in Skin Cancer

Charlotte Nübel
Teresa Amaral
Ulrike Leiter
Lukas Flatz
Andrea Forschner

Frontiers in Oncology

doi 10.3389/fonc.2023.1256800

3,233 views
1 citation

Case Report

Published on 24 Nov 2023

Case Report: Balancing immune responses – multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma

in Skin Cancer

Katrin Pape
Maria Protopapa
Muriel Schraad
Falk Steffen
Frauke Zipp
Stefan Bittner

Frontiers in Oncology

doi 10.3389/fonc.2023.1303141

2,916 views
3 citations

Original Research

Published on 08 Nov 2023

Cost items in melanoma patients by clinical characteristics and time from diagnosis

in Skin Cancer

Alessandra Buja
Claudia Cozzolino
Anna Zanovello
Ruggero Geppini
Andrea Miatton
Manuel Zorzi
Mariagiovanna Manfredi
Emanuela Bovo
Paolo Del Fiore
Saveria Tropea

Frontiers in Oncology

doi 10.3389/fonc.2023.1234931

2,722 views
2 citations

Original Research

Published on 30 Oct 2023

A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells

in Skin Cancer

Cheryl M. Cameron
Brian Richardson
Jackelyn B. Golden
Yee Peng Phoon
Banumathi Tamilselvan
Lukas Pfannenstiel
Samjhana Thapaliya
Gustavo Roversi
Xing-Huang Gao
Leah L. Zagore

Frontiers in Oncology

doi 10.3389/fonc.2023.1200387

4,406 views
2 citations

Case Report

Published on 27 Oct 2023

Covid-19, leukemia, and secondary malignancies of the skin – is there a connection: a case report and literature analysis

in Skin Cancer

Olga Bogomolets
Ewa Rojczyk
Roman Hryshchenko
Catherine Bogomolets
Oleksandr Berezkin

Frontiers in Oncology

doi 10.3389/fonc.2023.1265479

12,627 views
2 citations

Original Research

Published on 25 Oct 2023

Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers

in Skin Cancer

Elvelyn R. Fernandez
Deborah Tamura
Sikandar G. Khan
Sophie Momen
Hiva Fassihi
Robert Sarkany
John J. DiGiovanna
Kenneth H. Kraemer

Frontiers in Oncology

doi 10.3389/fonc.2023.1282823

3,373 views
8 citations

Original Research

Published on 23 Oct 2023

Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase)

in Skin Cancer

David Russo
Stéphane Dalle
Olivier Dereure
Laurent Mortier
Sophie Dalac-Rat
Caroline Dutriaux
Marie-Thérèse Leccia
Delphine Legoupil
Henri Montaudié
Eve Maubec

Frontiers in Oncology

doi 10.3389/fonc.2023.1250026

2,918 views
7 citations

Systematic Review

Published on 13 Oct 2023

Mapping the landscape of artificial intelligence in skin cancer research: a bibliometric analysis

in Skin Cancer

Qianwei Liu
Jie Zhang
Yanping Bai

Frontiers in Oncology

doi 10.3389/fonc.2023.1222426

5,984 views
7 citations

Brief Research Report

Published on 05 Oct 2023

The utility of high-frequency 18 MHz ultrasonography for preoperative evaluation of acral melanoma thickness in Chinese patients

in Skin Cancer

Nianzhou Yu
Kai Huang
Yixin Li
Zixi Jiang
Siliang Liu
Yuancheng Liu
Xiaowan Liu
Zeyu Chen
Renliang He
Tianhong Wei

Frontiers in Oncology

doi 10.3389/fonc.2023.1185389

3,104 views
3 citations

Editorial

Published on 28 Sep 2023

Editorial: The role of immunotherapy in melanomas

in Skin Cancer

Anna Fateeva
Suzie Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1293040

1,798 views
1 citation

Case Report

Published on 20 Sep 2023

Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma

in Skin Cancer

Karam Khaddour
Alice Zhou
Omar Butt
Jiayi Huang
George Ansstas

Frontiers in Oncology

doi 10.3389/fonc.2023.1276729

2,845 views
5 citations

Brief Research Report

Published on 18 Sep 2023

Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells

in Skin Cancer

Carlotta Guzzetti
Cristina Corno
Elisabetta Vergani
Luca Mirra
Emilio Ciusani
Monica Rodolfo
Paola Perego
Giovanni L. Beretta

Frontiers in Oncology

doi 10.3389/fonc.2023.1182853

2,673 views
4 citations

Original Research

Published on 07 Sep 2023

Development of an in vivo murine model of perineural invasion and spread of cutaneous squamous cell carcinoma of the head and neck

in Skin Cancer

Priscila O. de Lima
Natasa Broit
Johnson D. Huang
Jae H. Lim
Damien J. Gardiner
Ian S. Brown
Benedict J. Panizza
Glen M. Boyle
Fiona Simpson

Frontiers in Oncology

doi 10.3389/fonc.2023.1231104

4,848 views
3 citations

Original Research

Published on 06 Sep 2023

Cyclophosphamide augments the efficacy of in situ vaccination in a mouse melanoma model

in Skin Cancer

Noah Tsarovsky
Mildred Felder
Mackenzie Heck
Jacob Slowinski
Kayla Rasmussen
Sabrina VandenHeuvel
Jen Zaborek
Zachary S. Morris
Amy K. Erbe
Paul M. Sondel

Frontiers in Oncology

doi 10.3389/fonc.2023.1200436

2,695 views
1 citation

Case Report

Published on 29 Aug 2023

Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma

in Skin Cancer

Nakul Dar
Sarah E. Gradecki
Elizabeth M. Gaughan

Frontiers in Oncology

doi 10.3389/fonc.2023.1217179

2,736 views
1 citation

Original Research

Published on 17 Aug 2023

Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1

in Skin Cancer

Eszter Anna Janka
Beatrix Ványai
Imre Lőrinc Szabó
Tünde Toka-Farkas
Tünde Várvölgyi
Anikó Kapitány
Andrea Szegedi
Gabriella Emri

Frontiers in Oncology

doi 10.3389/fonc.2023.1237643

3,111 views
7 citations

Original Research

Published on 17 Aug 2023

Causal association between serum 25-Hydroxyvitamin D levels and cutaneous melanoma: a two-sample Mendelian randomization study

in Skin Cancer

Beichen Cai
Qian Lin
Ruonan Ke
Xiuying Shan
Jiaqi Yu
Xuejun Ni
Xinjian Lin
Biao Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1154107

5,187 views
9 citations

Editorial

Published on 08 Aug 2023

Editorial: Women in skin cancer vol II: 2022

in Skin Cancer

Selma Ugurel
Sapna P. Patel

Frontiers in Oncology

doi 10.3389/fonc.2023.1253081

1,871 views
1 citation

Case Report

Published on 01 Aug 2023

Case Report: Keratoacanthoma and type I diabetes secondary to treatment with PM8001, a bifunctional fusion protein targeting TGF-β and PD-L1

in Skin Cancer

Rongbin Qi
Hailing Xu
Xinyu Fu
Yingying Yu
Dongqing Lv
Yujing Li
Susu He

Frontiers in Oncology

doi 10.3389/fonc.2023.1046266

2,639 views
3 citations

Original Research

Published on 13 Jul 2023

Angiopoietin-2 expression and its relationship with lymphangiogenesis and clinicopathological characteristics in cutaneous malignant melanoma

in Skin Cancer

Wei Zheng
Wei Ju
Xi-Hu Yang
Zhi-Xin Yan

Frontiers in Oncology

doi 10.3389/fonc.2023.1113604

2,743 views
2 citations

Original Research

Published on 13 Jul 2023

A practical nomogram and risk stratification system predicting the cancer-specific survival for patients aged >50 with advanced melanoma

in Skin Cancer

Qiufen Xi
Xiaoou Lu
Jiali Zhang
Da Wang
Yu Sun
Hongquan Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1166877

2,899 views
2 citations

Case Report

Published on 05 Jul 2023

Case report: Metastatic Merkel cell carcinoma presenting seven years after loco-regional disease resection of primary tumor with interval in-transit and nodal metastases

in Skin Cancer

Joshua Rusheen
James Clune
Stephan Ariyan
Raymond Baumann
Harriet Kluger
Kelly Olino
Sarah Weiss

Frontiers in Oncology

doi 10.3389/fonc.2023.1217816

2,811 views
4 citations

Original Research

Published on 23 Jun 2023

Mapping knowledge landscapes and emerging trends of the biomarkers in melanoma: a bibliometric analysis from 2004 to 2022

in Skin Cancer

Yantong Wan
Junyi Shen
Yinghao Hong
Jinghua Liu
Tieliu Shi
Junwei Cai

Frontiers in Oncology

doi 10.3389/fonc.2023.1181164

6,863 views
16 citations

Review

Published on 19 Jun 2023

Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations

in Skin Cancer

Lucía Vázquez-Montero
María del Carmen Álamo de la Gala
Luis de la Cruz-Merino

Frontiers in Oncology

doi 10.3389/fonc.2023.1187840

15,730 views
7 citations

458 articles

articles

Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanoma

Case Report: Balancing immune responses – multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma

Cost items in melanoma patients by clinical characteristics and time from diagnosis

A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells

Covid-19, leukemia, and secondary malignancies of the skin – is there a connection: a case report and literature analysis

Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers

Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase)

Mapping the landscape of artificial intelligence in skin cancer research: a bibliometric analysis

The utility of high-frequency 18 MHz ultrasonography for preoperative evaluation of acral melanoma thickness in Chinese patients

Editorial: The role of immunotherapy in melanomas

Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma

Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells

Development of an in vivo murine model of perineural invasion and spread of cutaneous squamous cell carcinoma of the head and neck

Cyclophosphamide augments the efficacy of in situ vaccination in a mouse melanoma model

Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma

Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1

Causal association between serum 25-Hydroxyvitamin D levels and cutaneous melanoma: a two-sample Mendelian randomization study

Editorial: Women in skin cancer vol II: 2022

Case Report: Keratoacanthoma and type I diabetes secondary to treatment with PM8001, a bifunctional fusion protein targeting TGF-β and PD-L1

Angiopoietin-2 expression and its relationship with lymphangiogenesis and clinicopathological characteristics in cutaneous malignant melanoma

A practical nomogram and risk stratification system predicting the cancer-specific survival for patients aged >50 with advanced melanoma

Case report: Metastatic Merkel cell carcinoma presenting seven years after loco-regional disease resection of primary tumor with interval in-transit and nodal metastases

Mapping knowledge landscapes and emerging trends of the biomarkers in melanoma: a bibliometric analysis from 2004 to 2022

Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations